Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma
Abdominal Radiology · 2023
DOI: 10.1007/s00261-023-04079-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Abdominal Radiology, 2023. Verfasst von Shuang Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical S…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To develop a nomogram based on preoperative clinical and magnetic resonance imaging (MRI) features for the microvascular invasion (MVI) status in solitary intrahepatic mass-forming cholangiocarcinoma (sIMCC) and to evaluate whether it could predict recurrence-free survival (RFS). METHODS: We included 115 cases who experienced MRI examinations for sIMCC with R0 resection. The preoperative clinical and MRI features were extracted. Independent predictors related to MVI+ were evaluated by stepwise multivariate logistic regression, and a nomogram was constructed. A receiver operating characteristic (ROC) curve was used to assess the predictive ability. All patients were classified into high- and low-risk groups of MVI. Then, the correlations of the nomogram with RFS in patents with sIMCC were analyzed by Kaplan-Meier method. RESULTS: The occurrence rate of MVI+ was 38.3% (44/115). The preoperative independent predictors of MVI+ were carbohydrate antigen 19-9 > 37 U/ml, tumor size > 5 cm, and an ill-defined tumor boundary. Integrating these predictors, the nomogram exerted a favorable diagnostic performance with areas under the ROC curve of 0.767 (95% confidence interval [CI] 0.654-0.881) in the development cohort, and 0.760 (95% CI 0.591-0.929) in the validation cohort. In the RFS analysis, significant differences were observed between the high- and low-risk MVI groups (6-month RFS rates: 64.5% vs. 78.8% and 46.7% vs. 82.4% in the development and validation cohorts, respectively) (P < 0.05). CONCLUSIONS: A nomogram based on clinical and MRI features is a potential biomarker of MVI and may be a potent method to classify the risk of recurrence in patients with sIMCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, #17 Panjiayuan nanli, Chaoya…
Zitieren
APA
Chen, S., Wan, L., Zhao, R., Peng, W., Liu, X., Li, L., & Zhang, H. (2023). Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma. Abdominal Radiology. https://doi.org/10.1007/s00261-023-04079-6
Vancouver
Chen S, Wan L, Zhao R, Peng W, Liu X, Li L, et al. Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma. Abdominal Radiology. 2023. doi:10.1007/s00261-023-04079-6
BibTeX
@article{Chen2023,
author = {Chen, Shuang and Wan, Lijuan and Zhao, Rui and Peng, Wenjing and Liu, Xiangchun and Li, Lin and Zhang, Hongmei},
title = {Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma},
journal = {Abdominal Radiology},
year = {2023},
doi = {10.1007/s00261-023-04079-6}
}
EUVIMED